EVC2 and lung cancer: Given the value of sensitivity to detect lung cancer at an earlier stage, FIBA 6–15 (87.1%), APOA4 273–283 (61.3%), FIBA 5–16 (58.1%), and LBN 306–313 (58.1%) appeared to be the good biomarker candidates.